(R)-4,11-Dihydroxy-5,10-dioxo-N-(pyrrolidin-3-yl)-5,10-dihydroanthra[2,3-b]thiophene-3-carboxamide

ID: ALA4782803

PubChem CID: 162664772

Max Phase: Preclinical

Molecular Formula: C21H16N2O5S

Molecular Weight: 408.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1c2ccccc2C(=O)c2c1c(O)c1scc(C(=O)N[C@@H]3CCNC3)c1c2O

Standard InChI:  InChI=1S/C21H16N2O5S/c24-16-10-3-1-2-4-11(10)17(25)15-14(16)18(26)13-12(8-29-20(13)19(15)27)21(28)23-9-5-6-22-7-9/h1-4,8-9,22,26-27H,5-7H2,(H,23,28)/t9-/m1/s1

Standard InChI Key:  DFYGFCHVGWDZCQ-SECBINFHSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   38.1300  -11.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1289  -12.1405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8369  -12.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8352  -10.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5438  -11.3174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5426  -12.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2527  -12.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2551  -10.9035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9697  -11.3194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9684  -12.1405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6778  -12.5503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6762  -10.9099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3861  -11.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3865  -12.1378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1681  -12.3914    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   43.6509  -11.7263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1676  -11.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2551  -10.0863    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.2522  -13.3711    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.6739  -10.0927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.6791  -13.3675    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.4197  -10.2845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.2190  -10.1142    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.8726   -9.6774    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.4711   -9.3369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2475   -9.0830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2472   -8.2658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.4698   -8.0136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.9899   -8.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  2  0
 12  9  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
  8 18  2  0
  7 19  2  0
 12 20  1  0
 11 21  1  0
 17 22  1  0
 22 23  1  0
 22 24  2  0
 25 23  1  6
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4782803

    ---

Associated Targets(Human)

CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.44Molecular Weight (Monoisotopic): 408.0780AlogP: 2.18#Rotatable Bonds: 2
Polar Surface Area: 115.73Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.05CX Basic pKa: 10.32CX LogP: 2.01CX LogD: 1.98
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.38Np Likeness Score: -0.18

References

1. Tikhomirov AS,Litvinova VA,Andreeva DV,Tsvetkov VB,Dezhenkova LG,Volodina YL,Kaluzhny DN,Treshalin ID,Schols D,Ramonova AA,Moisenovich MM,Shtil AA,Shchekotikhin AE.  (2020)  Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.,  199  [PMID:32428792] [10.1016/j.ejmech.2020.112294]

Source